Joint Commission offers guidance on reducing UTIs

A new "R3 Report" from the Joint Commission (JC) offers hospitals information on ways to prevent catheter-associated urinary tract infections (UTIs) in hospitals.

Each year, hospitals see approximately 450,000 catheter-associated UTIs. This makes them the leading cause of healthcare-associated infection in hospitals, according to a JC statement, announcing the release of the report.

The report is designed to help hospitals understand specific elements of performance needed to meet the JC’s National Patient Safety Goal on urinary tract infections in hospitals, which will go into effect Jan. 1, 2012.

The goal will require hospitals and critical access hospitals to:
  • Insert indwelling urinary catheters according to established evidence-based guidelines.
  • Manage indwelling urinary catheters according to established evidence-based guidelines.
  • Measure and monitor catheter-associated urinary tract infection prevention processes and outcomes in high-volume areas.

The "R3 Report" provides the rationale for the goal, reference information, results of feedback from the field and level of evidence for each element of performance.

To read the full report, click here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.